ASSESSMENT OF GENOMIC COLLECTION BY CHINA.

SEC. 702. ASSESSMENT OF GENOMIC COLLECTION BY CHINA. (a) Assessment Submitted to Congressional Intelligence Committees.— (1) Requirement.—Not later than 180 days after the date of the enactment of this Act, the Director of National Intelligence, in consultation with the heads of other entities of the United States Government the Director determines appropriate, shall submit to the congressional intelligence committees an assessment of the plans, intentions, capabilities, and resources of China devoted to biotechnology, and the objectives underlying those plans, intentions, capabilities, and resources. (2) Elements.—The assessment under paragraph (1) shall include— (A) a detailed analysis of efforts undertaken by China to acquire foreign-origin biotechnology, research and development, and genetic information, including technology owned by United States companies, research by United States institutions, and the genetic information of United States citizens; (B) identification of China-based organizations conducting or directing efforts described in subparagraph (A), including information about the ties between those organizations and the Chinese government, the Chinese Communist Party, or the People’s Liberation Army; and (C) a detailed analysis of the resources of the intelligence community devoted to biotechnology, including synthetic biology and genomic-related issues, and a plan to improve understanding of these issues and ensure the intelligence community has the requisite expertise. (3) Form.—The assessment under paragraph (1) shall be submitted in unclassified form, but may include a classified annex. (b) Assessment Submitted to Certain Other Committees.— (1) Requirement.—Not later than 180 days after the date of the enactment of this Act, the Director of National Intelligence, in consultation with the heads of other entities of the United States Government the Director determines appropriate, shall submit to the appropriate congressional committees an assessment of the plans, intentions, capabilities, and resources of China devoted to biotechnology, and the objectives underlying those plans, intentions, capabilities, and resources. (2) Elements.—The assessment required by paragraph (1) shall include the elements described in subparagraphs (A) and (B) of subsection (a)(2). (3) Form.—The assessment under paragraph (1) shall be submitted in unclassified form. (4) Appropriate congressional committees defined.—In this subsection, the term “appropriate congressional committees” means— (A) the Committee on Armed Services, the Committee on Health, Education, Labor, and Pensions, and the Committee on Foreign Relations of the Senate; and (B) the Committee on Armed Services, the Committee on Energy and Commerce, and the Committee on Foreign Affairs of the House of Representatives.